Printer Friendly

Articles from United Kingdom Pharmaceuticals (May 29, 2019)

1-15 out of 15 article(s)
Title Author Type Words
Allergan plc (NYSE: AGN) - Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis -- 17/5/2019. 394
Allergan plc (NYSE: AGN). 2725
Amgen UK (NYSE: AMGN). 2263
AstraZeneca (NYSE: AZN). 13297
AstraZeneca - Trial reflecting real-world practice showed a reduction in the rate of asthma attacks compared to the most commonly used reliever therapy -- 20/5/2019. 520
Brinton Healthcare UK ltd. 124
Bristol Myers Squibb UK. 1902
Eli Lilly and Company UK (NYSE: LLY) - Lilly's Lower-Priced Insulin Now Available -- 22/5/2019. 441
Eli Lilly and Company UK. 5621
GlaxoSmithKline (LSE: GSK) - GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over -- 23/5/2019. 412
GlaxoSmithKline (LSE: GSK). 14160
Pfizer UK. 4147
Shire plc UK (LSE: SHP, NASDAQ: SHPG). 3809
The Industry. 446
VECTURA (LSE: VEC) - Vectura receives $2.5m milestone payment for the European regulatory submission of QVM149 -- 24/5/2019. 252

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters